Analytical Data
-
基因名
ASP2
- Application
-
别名
(Secreted protein ASP-2)
-
种属
Necator americanus
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q7Z1H1
-
表达区间
20-210aa
-
分子量
26.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The ASP2 protein, a member of the aspartic protease family, has garnered significant interest in biomedical research due to its potential implications in various physiological and pathological processes. Originally identified in fungi, ASP2 is believed to play a critical role in protein degradation, metabolism, and cellular signaling. Its importance is underscored by its involvement in diseases where dysregulated proteolytic activity can lead to inflammation, cancer progression, and neurodegenerative disorders. Recent studies have aimed to understand the structural and functional properties of ASP2 through recombinant protein techniques, allowing for the production of purified ASP2 variants for detailed biochemical characterization. This research not only enhances our understanding of ASP2's enzymatic mechanisms but also provides insights into its substrate specificity and potential as a therapeutic target. By elucidating the functional aspects of ASP2, researchers hope to develop novel interventions for diseases associated with aberrant protease activity, making it a promising candidate in the field of drug discovery and development. Overall, the study of ASP2 recombinant protein represents a significant step towards harnessing its biological potential for therapeutic applications.
